Insider Buying: Bioventix PLC (LON:BVXP) Insider Buys 61 Shares of Stock

Bioventix PLC (LON:BVXP) insider Bruce Hiscock purchased 61 shares of Bioventix stock in a transaction dated Monday, December 23rd. The stock was bought at an average price of GBX 273 ($3.42) per share, for a total transaction of £166.53 ($208.68).

Bruce Hiscock also recently made the following trade(s):

• On Friday, November 22nd, Bruce Hiscock bought 24 shares of Bioventix stock. The shares were bought at an average price of GBX 3,822 ($47.89) per share, for a total transaction of £917.28 ($1,149.47).
• On Wednesday, October 30th, Bruce Hiscock purchased 300 shares of Bioventix stock. The stock was bought at an average cost of GBX 3,330 ($41.73) per share, with a total value of £9,990 ($12,518.80).

Bioventix Price Performance

Bioventix stock opened at GBX 3,174.76 ($39.78) on Friday. The firm has a market capitalization of £165.72 million, a price-to-earnings ratio of 1,947.70 and a beta of 0.35. The company’s 50 day simple moving average is GBX 3,612.25 and its 200 day simple moving average is GBX 3,977.11. Bioventix PLC has a fifty-two week low of GBX 2,977 ($37.31) and a fifty-two week high of GBX 5,100 ($63.91).

Bioventix Increases Dividend

The company also recently declared a dividend, which was paid on Thursday, November 21st. Stockholders of record on Thursday, November 7th were issued a GBX 87 ($1.09) dividend. This is a positive change from Bioventix’s previous dividend of $68.00. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. Bioventix’s payout ratio is 9,693.25%.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.